Zobrazeno 1 - 10
of 157
pro vyhledávání: '"Susanne G Warner"'
Autor:
Yanghee Woo, Susanne G Warner, Rula Geha, Marianne M Stanford, Penelope Decarolis, Masmudur M Rahman, Samuel Singer, Grant McFadden, Yuman Fong
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 15 (2021)
Background: Myxoma virus (MYXV) is an oncolytic poxvirus that lacks the gene for 1 of the subunits of ribonucleotide reductase (RR), a crucial DNA synthesis and repair enzyme. The overexpression of RR has been implicated in the invasiveness of severa
Externí odkaz:
https://doaj.org/article/19721a6bf66b48e18231a56f96fff767
Autor:
Susanne G Warner, Dana Haddad, Joyce Au, Joshua S Carson, Michael P O’Leary, Christina Lewis, Sebastien Monette, Yuman Fong
Publikováno v:
Molecular Therapy: Oncolytics, Vol 3, Iss C (2016)
Stem-like tumor-initiating cells (TICs) are implicated in cancer progression and recurrence, and can be identified by sphere-formation and tumorigenicity assays. Oncolytic viruses infect, replicate in, and kill a variety of cancer cells. In this stud
Externí odkaz:
https://doaj.org/article/ce483fb83e0c4b5689007f069a412eb7
Autor:
Mustafa Raoof, Zeljka Jutric, Sidra Haye, Philip H. G. Ituarte, Beiqun Zhao, Gagandeep Singh, Laleh Melstrom, Susanne G. Warner, Bryan Clary, Yuman Fong
Publikováno v:
Cancer Medicine, Vol 9, Iss 17, Pp 6256-6267 (2020)
Abstract Background Despite evidence that liver resection improves survival in patients with colorectal cancer liver metastases (CRCLM) and may be potentially curative, there are no population‐level data examining utilization and predictors of live
Externí odkaz:
https://doaj.org/article/8323b49bb0634f3a803f847c347ede1c
Combined Liver and Colon Resection of Synchronous Colorectal Liver Metastases at a Quaternary Center
Autor:
Kevin Choong, Paul Wong, Lucas Thornblade, Kurt Melstrom, Lily Lai, Andreas Kaiser, Gagandeep Singh, Susanne G. Warner, Marwan Fakih, Yuman Fong, Laleh G. Melstrom
Publikováno v:
Journal of Surgical Research. 288:252-260
Autor:
Mustafa Raoof, Andrew M. Blakely, Laleh G. Melstrom, Byrne Lee, Susanne G. Warner, Vincent Chung, Gagandeep Singh, Yi‐Jen Chen, Yuman Fong
Publikováno v:
Cancer Medicine, Vol 8, Iss 13, Pp 5881-5890 (2019)
Abstract Purpose The American Society of Clinical Oncology guidelines recommend adjuvant chemoradiation (ACR) for margin‐positive (R1) and/or node‐positive (N+) pancreatic cancers. Our goal was to investigate if there is evidence of superiority o
Externí odkaz:
https://doaj.org/article/991813f299e84226b84904fd6ac3b0fe
Publikováno v:
Molecular Therapy: Oncolytics, Vol 13, Iss , Pp 93-106 (2019)
Cancer immunotherapy and the emergence of immune checkpoint inhibitors have markedly changed the treatment paradigm for many cancers. They function to disrupt cancer cell evasion of the immune response and activate sustained anti-tumor immunity. Onco
Externí odkaz:
https://doaj.org/article/d33d49ee949345dca50945b79a95b869
Autor:
Susanne G. Warner, Sang-In Kim, Shyambabu Chaurasiya, Michael P. O’Leary, Jianming Lu, Venkatesh Sivanandam, Yanghee Woo, Nanhai G. Chen, Yuman Fong
Publikováno v:
Molecular Therapy: Oncolytics, Vol 13, Iss , Pp 82-92 (2019)
Colon cancer has a high rate of recurrence even with good response to modern therapies. Novel curative adjuncts are needed. Oncolytic viral therapy has shown preclinical promise against colon cancer but lacks robust efficacy in clinical trials and ra
Externí odkaz:
https://doaj.org/article/018669abd663467ca3491a2b8b319288
Autor:
Audra J. Reiter, Susanne G. Warner, Herbert Chen, Angela M. Ingraham, Catherine J. Hunter, Julie Freischlag, Mehul V. Raval
Publikováno v:
Journal of Surgical Research. 285:A1-A6
Autor:
Ron Pery, Hallbera Gudmundsdottir, David M. Nagorney, Niv Pencovich, Rory L. Smoot, Cornelius A. Thiels, Mark J. Truty, Robert A. Vierkant, Susanne G. Warner, Michael L. Kendrick, Sean P. Cleary
Publikováno v:
HPB. 25:339-346
Publikováno v:
Clinical and Translational Medicine, Vol 7, Iss 1, Pp 1-13 (2018)
Abstract Advances in the understanding of cancer immunotherapy and the development of multiple checkpoint inhibitors have dramatically changed the current landscape of cancer treatment. Recent large-scale phase III trials (e.g. PHOCUS, OPTiM) are est
Externí odkaz:
https://doaj.org/article/717c01ba82214ce3a3f50568703fc7c3